• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic expects rev from surgical bot system by FY2019

Medtronic expects rev from surgical bot system by FY2019

June 7, 2016 By Fink Densford

MedtronicOn Monday, Medical device giant Medtronic (NYSE:MDT) unveiled plans that would see income from a robotic surgery unit by 2019, an entry into the orthopedic hip and knee replacement market in 2017 and an application for FDA regulatory clearance for a hybrid closed-loop insulin pump this summer.

The company revealed these plans and outlined its financial strategies for the coming year yesterday during an investor day presentation.

Fridley, Minn.-based Medtronic said it expects to see revenue from its still-in-development robotic surgical system by the beginning of the fiscal year 2019,.

The company expects to launch the robot before FY2019 with the 1st units hitting the field in India, according to minimally invasive therapies group head Bryan Hanson.

The robotic system will go up against Intuitive Surgical‘s (NSDQ:ISRG) da Vinci system, as well as facing competition from a number of other emerging players, including Johnson & Johnson (NYSE:JNJ) and Google‘s (NSDQ:GOOG) Verb Surgical, which is already developing their own unit they hope to unveil by year’s end.

The robotic unit from Medtronic will aim to lower costs, Hanson said, and 150 employees are already at work in development of the system.

New hip and knee replacement devices are on the horizon for Medtronic. The company said it will enter the field of hip and knee replacement devices, facilitated by its purchase of Responsive Orthopedics, with the 1st knee available during the 1st half of 2017 and the 1st hip product in 2018.

The company also said that it expects to apply for FDA approval for the 1st “hybrid closed loop” insulin pump, designed to adjust insulin levels according to glucose reading, by the end of June.

Material from Reuters was used in this report.

Filed Under: Business/Financial News, Diabetes, Orthopedics, Surgical Robotics Tagged With: Medtronic

More recent news

  • Data backs DermaSensor skin cancer detection device
  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy